In Vitro Effects of SB202190 on Echinococcus granulosus
Authors:
Open Access
- 25 April 2013
- journal article
- Published by Korean Society for Parasitology in The Korean Journal of Parasitology
- Vol. 51 (2) , 255-258
Abstract
Spillage of cyst contents during surgical operation is the major cause of recurrence after hydatid cyst surgery. Instillation of a scolicidal agent into a hepatic hydatid cyst is the most commonly employed measure to prevent this complication. SB202190 is a pyridinyl imidazole derivative and is known to be a specific inhibitor of p38 MAPK. In the present study, the scolicidal effect of SB202190 was investigated. Freshly isolated Echinococcus granulosus protoscolices were subjected to SB202190 treatment (10, 20, 40, and 80 µM), and the effects on parasite viability were monitored by trypan blue staining. Corresponding effects were visualized by scanning and transmission electron microscopy. Dose-dependent protoscolex death within a few days of SB202190 treatment was observed. Although the in vitro scolicidal effect of SB202190 was satisfactory, the in vivo efficacy of this drug and also possible side effects remain to be further investigated.Keywords
This publication has 13 references indexed in Scilit:
- Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationExperimental Parasitology, 2011
- In vitro effectiveness of acidic and alkline solutions on scolices of hydatid cystParasitology Research, 2010
- The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancerExpert Opinion on Investigational Drugs, 2009
- Efficacy of Chlorhexidine Gluconate During Surgery for Hydatid CystWorld Journal of Surgery, 2009
- Echinococcosis: a reviewInternational Journal of Infectious Diseases, 2009
- Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: Antiparasitic activities of p38 MAPK inhibitorsBiochemical Pharmacology, 2008
- In Vitro Effectiveness of Different Chemical Agents on Scolices of Hydatid CystJournal of Investigative Surgery, 2008
- Pharmacokinetics of ML3403 ({4-[5-(4-Fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-Type p38 Mitogen-Activated Protein Kinase InhibitorDrug Metabolism and Disposition, 2007
- EchinococcosisThe Lancet, 2003
- Severe Hypernatremia After Hypertonic Saline Irrigation of Hydatid CystsAnesthesia & Analgesia, 2002